On September 29, 2026, Teva Pharmaceuticals USA, Inc initiated a recall of Metoclopramide Tablets, USP, 5 mg, due to the presence of foreign tablets or capsules. The recall, classified as Class II, may cause temporary or reversible health problems and affects products distributed nationwide in the U.S. The recall numbers are D-0038-2027, and it is currently ongoing, according to the Food and Drug Administration.

Press Release: Food and Drug Administration

Published October 21, 2026. Reproduced in full from the Food and Drug Administration.

Teva Pharmaceuticals USA, Inc drug recall

  • Recalling company: Teva Pharmaceuticals USA, Inc
  • Classification: Class II (may cause temporary or reversible health problems)
  • Recall numbers: D-0038-2027
  • Status: Ongoing
  • Distribution: US Nationwide.
  • Recall started: September 29, 2026

What was recalled

Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05

Why

Presence of Foreign Tablets/Capsules

This drug recall appears in the FDA's weekly enforcement report. Details: FDA recall event 100013.